VIR FY 2018 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$868,000+482.6% YoY

Gross Profit

-$99M-11447.1% margin

Operating Income

-$119M-13674.2% margin

Net Income

-$116M-13350.7% margin

EPS (Diluted)

$-1.20

Cash Flow

Operating Cash Flow

-$94M

Free Cash Flow

-$102M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$192M

Total Liabilities

$371M

Stockholders' Equity

-$179M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$868,000	$149,000	+482.6%
Gross Profit	-$99M	-$62M	-59.3%
Operating Income	-$119M	-$81M	-45.6%
Net Income	-$116M	-$70M	-65.9%